Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.07.07.737004

The projection basis determines the information ceiling for perturbation prediction

Abstract

Recent benchmarks show that deep-learning models for perturbation prediction do not outperform simple baselines operating in principal-component (PCA) space. We explain this with an information-theoretic ceiling: for any orthonormal projection basis{Phi} , the squared correlation between prediction and truth is bounded by the variance the basis explains (r2 [≤] VE), so no model complexity can recover signal discarded at projection. On chemical perturbations (sciPlex3, LINCS L1000), the eigenbasis of a gene association network captures only 10-12% of drug-response variance and yields chance-level predictions, while PCA captures 90-99%. Graph wavelets built on the same network recover [~]88%, localising the drug signal in high-frequency modes that the standard low-pass eigenbasis discards. On CRISPRa genetic perturbations the ranking inverts: the network basis outperforms PCA across all dimensions tested. Controls on topology, null networks and data leakage confirm the effect is structural. The right basis depends on the perturbation modality: PCA captures the variance that drives chemical responses, the network basis captures the cascade structure that drives genetic ones, and bases that access the networks full graph spectrum (such as graph wavelets) recover both from the same topology.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

BIANCO, S.. 2026-07-09. The projection basis determines the information ceiling for perturbation prediction. https://doi.org/10.64898/2026.07.07.737004

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Monocyte-Mimetic Nanoparticle Delivery of Verteporfin Promotes Plaque-Stabilizing Remodeling in Atherosclerosis

Background: Despite advances in lipid-lowering and anti-inflammatory therapies, pharmacological strategies that act directly within established atherosclerotic lesions to suppress plaque progression remain limited. We recently developed a monocyte-mimetic nanoparticle (MoNP) platform that selectively targets inflamed endothelium and delivers Verteporfin (VP), termed MoNP-VP, to suppress YAP/TAZ-associated endothelial activation and plaque development. Here, we extend this biomimetic nanotherapy by defining the pharmacological effects of MoNP-VP within atherosclerotic vessels and evaluating its therapeutic efficacy in pre-existing plaques under distinct lipid burden. Methods: MoNP-VP were formulated by encapsulating VP in polymeric cores followed by cloaking with mouse monocyte membranes. Partial ligation was performed in ApoE-deficient mice, and single-cell RNA sequencing was used to define pharmacodynamic responses in carotid lesions. Proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function was induced in wild-type mice to generate pre-existing aortic lesions, followed by continued high-fat-diet or switching to chow to evaluate MoNP-VP efficacy under persistent hyperlipidemia and lipid-lowering conditions. Results: Single-cell analysis revealed that MoNP-VP remodeled the plaque microenvironment in carotid arteries, selectively reducing foamy macrophage populations while enriching vascular stromal populations associated with fibrotic remodeling. In mice with pre-existing aortic plaques, MoNP-VP suppressed lesion progression and reduced macrophage content under persistent hyperlipidemia. Following diet-induced lipid lowering, MoNP-VP further reduced macrophage accumulation despite no significant change in plaque size. Across both settings, MoNP-VP increased fibroblast-like cell populations and collagen deposition accompanied by activation of TGF{beta} signaling, features consistent with a more stable plaque. Importantly, repeated MoNP-VP administration was well tolerated and elicited no overt systemic toxicity. Conclusion: These findings bridge mechanistic insight and therapeutic efficacy in pre-established plaques by demonstrating that MoNP-VP remodels the inflammatory plaque microenvironment and promotes lesion stabilization, supporting its translational potential as a precision nanotherapy for atherosclerosis.

molecular biology↗

Dna2-intrinsic condensation regulates DNA end resection and reveals evolutionary redistribution of condensate grammar

Eukaryotic cells commonly use biomolecular condensation of DNA double-strand break (DSB) repair scaffolds and signaling assemblies to organize repair reactions in space and time. Yet whether DSB end-processing enzymes themselves encode tunable phase separation that potentiates resection remains unclear. Here we show that the long-range resection enzyme Dna2 forms liquid-like condensates through an intrinsically disordered region that is necessary and sufficient for phase separation and catalytic enhancement in Saccharomyces cerevisiae. Dna2 condensates concentrate DNA substrates and enhance end processing, whereas disrupting condensate formation impairs repair kinetics, checkpoint signaling, and chromosome stability. Grafting of the heterologous intrinsically disordered region of human FUS partly rescues condensate formation and function, and Cdk1-dependent phosphorylation sites tune condensate stability and enzymatic output in cis and in trans. Machine-learning-based analysis reveals that condensation-promoting features of fungal Dna2 are shared with a restricted set of human DNA2-associated resection regulators. Together, these findings define phosphorylation-tuned, enzyme-intrinsic phase separation as an organizational principle of DSB end resection while supporting a model in which condensation-promoting features are redistributed among factors operating within conserved genome maintenance pathways.

molecular biology↗

Multiomics Reveals IGF-1 c.258A > G Reduces Triacylglycerol Containing Medium-Chain Fatty Acid in Milk

Fatty acid composition of milk triacylglycerol (TAG) is important for neonatal growth. We previously identified a synonymous mutation widely distributed in human populations, IGF-1 c.258A > G, which decreased milk TAG content in gene-edited mice. So far, the acyl chain composition of affected TAGs, underlying molecular mechanism, and cross-species conservation remain unclear. Here, integrated transcriptomic and metabolomic analyses of mouse mammary glands revealed that this mutation downregulates IGF-1 expression and elevates lipoprotein lipase (LPL) activity, and potential associations between IGF-1 and peroxisome proliferator-activated receptor {gamma} (PPARG), fatty acid synthase (FASN) and lipin 1 (LPIN1). Association analysis in 295 Bama pigs carrying this gene polymorphism showed reduced milk lipid content in sows; further, correspondingly lower litter weight was significantly associated with the genotype. Integrated metabolomic profiling of mouse mammary glands and porcine milk demonstrated insufficient production of lauric and myristic acids. Accordingly, supplementing these two fatty acids restored TAG content. Mechanistically, IGF-1 promotes triacylglycerol-containing medium-chain fatty acid (MCFA-TAG) synthesis by activating the PPARG-FASN/LPIN1 axis, whereas increased LPL activity indirectly suppresses this axis through long-chain fatty acid accumulation. Together, our results reveal the molecular mechanism whereby this mutation affects milk lipid synthesis, providing insights into the regulation of MCFA-TAG synthesis.

molecular biology↗